Overview

An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.

Status:
Completed
Trial end date:
2019-10-29
Target enrollment:
Participant gender:
Summary
Study of what the body does to drug BMS-986165 when it is taken together with pyrimethamine
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165
Pyrimethamine